This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Advanced Cancer
and you are
between 18 and 70
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To study the pharmacokinetic characteristics of TQ-B3101 in the human body, recommend a reasonable regimen for subsequent research.

Provided treatments

  • Drug: TQ-B3101

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03019276. The sponsor of the trial is Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and it is looking for 20 volunteers for the current phase.
Official trial title:
Phase I Study of Tolerance and Pharmacokinetics of TQ-B3101 in Patients With Advanced Cancer